MetaCap

Who Owns abrdn Life Sciences Investors Stock?

NYSE: HQLFinanceInvestment ManagersUSD

15.38-0.61 (-3.81%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
27.61%
Institutional holders
97
  • Institutions 27.6%
  • Insiders 0.0%
  • Public and other 72.4%

Who owns abrdn Life Sciences Investors stock?

Institutional investors own about 27.6% of abrdn Life Sciences Investors's shares, spread across 97 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.00% of HQL.

The largest institutional holders are Morgan Stanley (6.81%), Penserra Capital Management LLC (2.76%) and Raymond James Financial, Inc. (2.43%). Together, the top 10 institutions control 19.7% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their HQL positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of HQL

abrdn Life Sciences Investors top institutional holders
InstitutionShares% HeldChange
Morgan Stanley2.07M6.81%+16.8%
Penserra Capital Management LLC838.89K2.76%+4.0%
Raymond James Financial, Inc.740.06K2.43%+7.4%
LPL Financial LLC552.75K1.82%+7.5%
Needham Investment Management, L.L.C.443.04K1.46%0.0%
Flagship Harbor Advisors, LLC417.37K1.37%+4.1%
Allspring Global Investments Holdings, LLC416.02K1.37%-8.6%
Advisors Asset Management, Inc.169.81K0.56%+5.9%
Ameriprise Financial, Inc.168.64K0.55%-13.7%
Formidable Asset Management, Llc166.32K0.55%+0.7%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of HQL

abrdn Life Sciences Investors top fund holders
FundShares% Held
Amplify ETF Trust-Amplify CEF High Income ETF834.89K2.75%
RIVERNORTH OPPORTUNITIES FUND INC.-Rivernorth Opportunities Fund Inc150.00K0.49%
Modern Capital Funds Trust-Modern Capital Tactical Income Fund122.77K0.40%
First TRT Exch-Trd Fd. VIII-First TRT Income Opportunities ETF73.41K0.24%
Rydex Variable Trust-Multi-Hedge Strategies Fund2710.00%
Rydex Series Funds-Guggenheim Multi-Hedge Strategies Fund970.00%

Frequently asked questions

Who is the largest shareholder of abrdn Life Sciences Investors?

Morgan Stanley is the largest institutional shareholder of HQL, owning 6.81% of shares outstanding (2.07M shares) as of its latest 13F filing.

What percentage of abrdn Life Sciences Investors is owned by institutions?

Institutions own about 27.6% of HQL shares and 27.6% of the public float.

How much of abrdn Life Sciences Investors do insiders own?

Insiders, such as officers and directors, own about 0.00% of HQL shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related